Amy Flaxman

Amy is a Senior Research Facilitator for UK Biobank (UKB) who joined Oxford Population Health in 2023. Her role involves helping manage current data linkages and facilitating the expansion of access to electronic health-related records for the whole UKB cohort. Amy is also responsible for scoping out, developing and delivering major new enhancements to UKB in order to collect further data from participants.

Prior to joining Oxford Population Health, Amy had 10 years’ experience within the University of Oxford in vaccine development. She completed her DPhil in Clinical Medicine and early postdoctoral work at the Jenner Institute working on pre-clinical vaccine development for S. aureus and Ebola respectively.

She then moved into clinical trials as a Senior Post-Doctoral Immunologist working firstly on malaria vaccine studies, followed by COVID vaccine trials and most recently on Paratyphoid vaccine and challenge studies at Oxford Vaccine Group.